Price$49.92+20.68 (+70.73%)
2026-05-212026-08-25
News · 26 weeks74+33%
2026-03-012026-08-23
Mix3990d
- Insider27(69%)
- SEC Filings5(13%)
- Other4(10%)
- Earnings2(5%)
- Analyst1(3%)
Latest news
25 items- INSIDERChief Executive Officer Farquhar John C.M. sold $1,361,500 worth of shares (27,230 units at $50.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 360,814 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. sold $1,470,420 worth of shares (32,676 units at $45.00) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 388,044 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Medical Officer Rogers Campbell exercised 9,219 shares at a strike of $19.00 and sold $380,099 worth of shares (9,219 units at $41.23) as part of a pre-agreed trading plan (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. sold $607,774 worth of shares (15,560 units at $39.06) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 420,720 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- SECSEC Form 144 filed by Heartflow Inc.144 - Heartflow, Inc. (0001464521) (Subject)
- SECSEC Form 144 filed by Heartflow Inc.144 - Heartflow, Inc. (0001464521) (Subject)
- SECSEC Form 10-Q filed by Heartflow Inc.10-Q - Heartflow, Inc. (0001464521) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Heartflow Inc.SCHEDULE 13G/A - Heartflow, Inc. (0001464521) (Subject)
- SECHeartflow Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Heartflow, Inc. (0001464521) (Filer)
- PRHeartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceSAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights Total revenue of $64.1 million, a 48% increase year-over-yearGross margin of 83.0%, non-GAAP gross margin of 83.3%Net operating loss of $17.9 million; non-GAAP net operating loss of $7.9 million 2026 Annual Guidance Total revenue of $246 million to $250 million (approximately 40% to 42% growth year-over-year), compared to previous guidance of $228 million to $232 million (approximately 29% to 32% growth year-
- INSIDERChief Executive Officer Farquhar John C.M. sold $638,730 worth of shares (22,562 units at $28.31) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 436,280 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Accounting Officer Jones Marie L. was granted 1,661 units of Common Stock. and covered exercise/tax liability with 568 units of Common Stock., increasing direct ownership by 2% to 32,176 units (SEC Form 4) to cover taxes4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Financial Officer Verghese Vikram was granted 671 units of Common Stock. and covered exercise/tax liability with 2,010 units of Common Stock., increasing direct ownership by 20% to 254,559 units (SEC Form 4) to cover withholding tax4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Medical Officer Rogers Campbell covered exercise/tax liability with 2,272 shares, decreasing direct ownership by 3% to 86,459 units (SEC Form 4) (withholding tax)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Executive Officer Farquhar John C.M. covered exercise/tax liability with 7,751 shares, decreasing direct ownership by 2% to 458,842 units (SEC Form 4) (withholding tax)4 - Heartflow, Inc. (0001464521) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Heartflow Inc.SCHEDULE 13G/A - Heartflow, Inc. (0001464521) (Subject)
- INSIDERChief Executive Officer Farquhar John C.M. exercised 31,220 shares at a strike of $5.06, increasing direct ownership by 7% to 466,593 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- ANALYSTRobert W. Baird initiated coverage on Heartflow with a new price targetRobert W. Baird initiated coverage of Heartflow with a rating of Outperform and set a new price target of $34.00
- INSIDERChief Financial Officer Verghese Vikram exercised 22,522 units of Common Stock. at a strike of $2.22, increasing direct ownership by 10% to 255,898 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERDirector Lightcap Jeffrey C exercised 47,420 shares at a strike of $19.00, increasing direct ownership by 19% to 293,681 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERDirector Barabe Timothy C exercised 3,710 shares at a strike of $19.00, increasing direct ownership by 2% to 188,231 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Financial Officer Verghese Vikram exercised 22,522 units of Common Stock. at a strike of $2.22, increasing direct ownership by 11% to 233,376 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- PRHeartflow to Report Second Quarter 2026 Financial Results on August 13, 2026SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the second quarter of 2026 after market close on Thursday, August 13, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on August 13, 2026. Those interested in listening to the conference call should register online using this link. Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the start of the call. A l
- INSIDERDirector Barabe Timothy C exercised 5,000 shares at a strike of $19.00, increasing direct ownership by 3% to 184,521 units (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
- INSIDERChief Medical Officer Rogers Campbell exercised 9,219 shares at a strike of $19.00 and sold $237,113 worth of shares (9,219 units at $25.72) as part of a pre-agreed trading plan (SEC Form 4)4 - Heartflow, Inc. (0001464521) (Issuer)
HTFL FAQ
6 questionsWhere does HTFL stock trade?
Heartflow Inc. (HTFL) is listed on NASDAQ.What sector and industry is HTFL in?
Heartflow Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Heartflow Inc. go public?
Heartflow Inc. (HTFL) completed its IPO in 2025.What are analysts saying about HTFL?
Heartflow Inc. has had 8 recent analyst actions on file. The most recent action was from Robert W. Baird: Outperform with a $3400.00 price target on 2026-07-31. Recent price targets range from $3400.00 to $3800.00.What companies are similar to HTFL?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare HTFL side-by-side with any of them on Quantisnow.How can I track HTFL on Quantisnow?
Quantisnow aggregates Heartflow Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HTFL to receive live email and push alerts on every new disclosure.